I graduated with a PhD in chemistry from the University of Heidelberg, Germany in 1995. I spent a year as a Postdoc at Cornell University in Ithaca, NY, then worked as a medicinal chemist for GlaxoSmithKline in Cape Town, South Africa.
I joined Austin Health in 1998 as a radiochemist. Initially, I did a lot of carbon-11 work and established the procedure for the first C-11 PIB scan in Australia. I have extensive experience in performing first-in-human studies with neuroscience and oncology tracers labelled with C-11, F-18 and Zr-89. My main research interests are in synthesis automation, labelling of peptides ad antibodies as well as hypoxia.
Professor Michael Hofman appeared on 2GB Radio to talk about a recent major boost for cancer research at Peter MacCallum Cancer Centre.
25 February 2025
The Governor-General, Her Excellency the Honourable Sam Mostyn AC has announced the award of Australian Cancer Research Foundation’s (ACRF) 2024 grants at Government House in Canberra. The announcem
25 November 2024
Ultra-high field MRI is unveiling a picture of endurance, and helping to uncover the physical, social and emotional effects of Associate Professor Donna Urquhart’s incredible Antarctic ultramarathon
07 March 2024
31 October 2023
Rebecca V Robertson, Noemi Meylakh, Lewis S Crawford, Fernando A Tinoco Mendoza, Paul M Macey, Vaughan G Macefield, Kevin A Keay, Luke A Henderson
Read Publication
Joseph J. Bartlett, Catherine E. Davey, Leigh A. Johnston, Jinming Duan
Read Publication